Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL
SAN DIEGO — An investigational CAR T-cell therapy induced responses in nearly every single patient with childhood B-cell acute lymphoblastic leukemia (B-ALL), a researcher reported
SAN DIEGO — An investigational CAR T-cell therapy induced responses in nearly every single patient with childhood B-cell acute lymphoblastic leukemia (B-ALL), a researcher reported
SAN DIEGO — Children with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL) lived significantly longer without disease recurrence when they received the bispecific T-cell engager
SAN DIEGO — Treatment with eltrombopag (Promacta) for pediatric patients with newly diagnosed immune thrombocytopenia (ITP) led to a significantly higher rate of durable platelet
Efforts to reduce the nation’s persistently high maternal mortality rates involve state panels of experts that investigate and learn from each mother’s death. The panels